Fresh from the pipeline - Tigecycline

Tigecycline (Tygacil;Wyeth) was approved by the US FDA for the treatment of a range of bacterial infections in June 2005. It is the first in a new generation of tetracyclines known as glycylcyclines, which have been developed to overcome the problems of resistance to earlier tetracyclines.